| 前收盘价格 | 1.42 |
| 收盘价格 | 1.43 |
| 成交量 | 100,657 |
| 平均成交量 (3个月) | 5,022,491 |
| 市值 | 1,130,007,936 |
| 价格/销量 (P/S) | 1.45 |
| 股市价格/股市净资产 (P/B) | 0.870 |
| 52周波幅 | |
| 利润日期 | 5 May 2025 - 9 May 2025 |
| 营业毛利率 | -7.46% |
| 营业利益率 (TTM) | -18.05% |
| 稀释每股收益 (EPS TTM) | -0.080 |
| 季度收入增长率 (YOY) | 1.00% |
| 总债务/股东权益 (D/E MRQ) | 36.94% |
| 流动比率 (MRQ) | 3.43 |
| 营业现金流 (OCF TTM) | -183.49 M |
| 杠杆自由现金流 (LFCF TTM) | -129.55 M |
| 资产报酬率 (ROA TTM) | -8.12% |
| 股东权益报酬率 (ROE TTM) | -3.86% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 看跌 | 看跌 |
| Diagnostics & Research (全球的) | 看跌 | 看跌 | |
| 股票 | Opko Health, Inc. | 看涨 | 混合的 |
AIStockmoo 评分
1.3
| 分析师共识 | 5.0 |
| 内部交易活动 | 3.0 |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.30 |
|
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Value |
| 内部持股比例 | 55.26% |
| 机构持股比例 | 29.89% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 3.00 (HC Wainwright & Co., 110.53%) | 购买 |
| 中 | 2.63 (84.56%) | |
| 低 | 2.25 (Barrington Research, 57.90%) | 购买 |
| 平均值 | 2.63 (84.56%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 1.66 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 07 Apr 2025 | 3.00 (110.53%) | 购买 | 1.53 |
| 19 Mar 2025 | 3.00 (110.53%) | 购买 | 1.86 | |
| Barrington Research | 12 Mar 2025 | 2.25 (57.89%) | 购买 | 1.78 |
| 28 Feb 2025 | 2.25 (57.89%) | 购买 | 1.74 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合